课题基金 / 基金详情

Endothelial precursor dysfunction in development of diabetic acellular capillary

Endothelial precursor dysfunction in development of diabetic acellular capillary
糖尿病脱细胞毛细血管发育中的内皮前体功能障碍
批准号:
8009929
负责人:
Maria Bartolomeo Grant
金额:
$17.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 2012-01-31
关键词:
AcetylcholineActinsAcuteAdherenceAdultAdvanced Glycosylation End ProductsAffectAgeAnimal ModelAnimalsAreaArtsBiochemicalBiologicalBiological AssayBiological AvailabilityBlindnessBlood VesselsBlood capillariesBlood flowBradykininBrain Hypoxia-IschemiaCD34 geneCell DeathCell-Matrix JunctionCellsChronicCollagen Type IVConfocal MicroscopyCyclic GMPCyclic GMP-Dependent Protein KinasesCytokine ReceptorsCytoskeletonDNA Sequence RearrangementDataDefectDevelopmentDiabetes MellitusDiabetic RetinopathyDiabetic mouseDown-RegulationDropoutEndothelial CellsEndotheliumEnvironmentEpithelialEquilibriumFluorescence MicroscopyFunctional disorderGenerationsGrantGrowth FactorHematopoieticHome environmentHumanHypoxiaImageIn VitroIndividualInjection of therapeutic agentInjuryIschemiaLeadLesionMaintenanceMediator of activation proteinMembraneMicrofilamentsMigration AssayModelingMolecularMolecular MotorsMotorMutateNatureNitric OxideNitric Oxide DonorsNitric Oxide Signaling PathwayNitric Oxide SynthaseNude MicePECAM1 genePathway interactionsPatientsPericytesPhosphorylation SitePigmentsPlayPopulationProcessPropertyProtein IsoformsProteinsRegulationReperfusion InjuryResearch PersonnelRetinaRetinalReverse Transcriptase Polymerase Chain ReactionRodentRodent ModelRoleSecondary toSignal TransductionStaining methodStainsStreptozocinStromal Cell-Derived Factor 1Substance PTechniquesTestingTimeTransfectionVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth FactorsWestern WorldWorkbasecapillarycell motilitycell typediabeticdiabetic patientglycationglycosylated fibronectininjuredmatrigelmigrationnon-diabeticnovelpigment epithelium-derived factorpolymerizationprecursor cellprogramsproliferative diabetic retinopathyrepairedresponseretinal ischemiastemtoolvasodilator-stimulated phosphoprotein

项目摘要

项目成果

Maria Bartolomeo Grant的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Diabetic retinopathy (DR) is a primary cause of blindness of working age adults in the Western world. Early pericyte dropout and endothelial cell death result in the formation of acellular capillaries, which cause retinal hypoxia and ischemia and are important contributors to DR development. We have shown have that hematopoietic stem and endothelial precursor cells (EPC) readily home to the retina in healthy animals, but that EPC of diabetic animal and humans have a migratory defect. Our preliminary studies demonstrate that EPC dysfunction may provide a novel mechanism for development of acellular capillaries in diabetic retinopathy. Our data suggest that within EPCs, nitric oxide (NO) plays a key role in regulating the actin polymerization mediator, vasodilator-stimulated phosphoprotein (VASP). In diabetes, reduced bioavailability of NO can occur as a result of alterations in growth factor/cytokine receptor balance, downstream signaling, or downregulation of NO synthase (NOS) activation. Reduced NO can alter actin polymerization affecting EPC migration and their ability to carry out endothelial repair. Our hypothesis is that in diabetic individuals reduced NO bioavailability results in decreased EPC migration, attachment and invasion contributing to inadequate endothelial repair and development of acellular capillaries. State-of-the- art imaging, fluorescent activated cell sorter analysis, novel in vitro culture assays and diabetic animal models will be used in combination with biochemical and molecular biological techniques to test our hypothesis. We propose the following specific aims: Specific Aim 1: Our hypothesis predicts that diabetic EPCs will be unable to home to the retina and repopulate acellular capillaries whereas EPCs from normals will. Diabetic mice that have developed acellular retinal capillaries will be injected systemically with EPCs from nondiabetic rodents and the degree of vascular repair examined. Specific Aim 2: Our hypothesis predicts that NO regulates EPC migration .directly by promoting cytoskeletal changes. We will determine which factors regulate EPC NOS isoform expression and NO generation and delineate the NO signaling pathway that regulates cytoskeletal dysfunction in diabetic EPCs. Specific Aim 3: Our hypothesis predicts that diabetic CD34+ EPC cells have defective attachment and invasion. We will determine whether EPC attachment is dependent upon inherent properties of the EPC or the local matrix environment and evaluate human diabetic and nondiabetic CD34+ cell attachment to normal and glycated matrix. The exciting implication of our hypothesis is that early repair of the EPC migratory defect may deter the subsequent development of proliferative diabetic retinopathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Correction of diabetic retinopathy by mitochondrial transfer
  • 批准号:
    10658455
  • 项目类别:
  • 资助金额:
    $57.12万
  • 财政年份:
    2023
  • 负责人:
    Maria Bartolomeo Grant
  • 依托单位:
Dysfunction of endothelial precursor subtypes dictates the outcomes of diabetic r
Dysfunction of endothelial precursor subtypes dictates the outcomes of diabetic r
Vascular Reparative Mechanism by ACE2/Ang-(1-7)in Diabetes
海外基金